Tubular kidney injury molecule-1 in protein-overload nephropathy
about
Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatologyIncreased susceptibility of aging kidney to ischemic injury: identification of candidate genes changed during aging, but corrected by caloric restrictionTissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in ratsKidney injury molecule-1 is an early noninvasive indicator for donor brain death-induced injury prior to kidney transplantationAge-related differences in susceptibility to cisplatin-induced renal toxicity.The metabolic profile of a rat model of chronic kidney disease.Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal diseaseKidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies.The effect of progressive glomerular disease on megalin-mediated endocytosis in the kidneyKidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury.Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetesFactor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate.Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy.Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathyGlomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy.Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trialEffects of long-acting erythropoietin analog darbepoetin-α on adriamycin-induced chronic nephropathy.Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicityEarly Markers of Tubulointerstitial Fibrosis in Children With Idiopathic Nephrotic Syndrome: Preliminary Report.Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury.Mechanistic biomarkers for cytotoxic acute kidney injury.Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis.Cell therapy with human renal cell cultures containing erythropoietin-positive cells improves chronic kidney injury.Differential effects of sex steroids in young and aged female mRen2.Lewis rats: a model of estrogen and salt-sensitive hypertension.3-MCPD 1-Palmitate Induced Tubular Cell Apoptosis In Vivo via JNK/p53 Pathways.Mammalian Target of Rapamycin Mediates Kidney Injury Molecule 1-Dependent Tubule Injury in a Surrogate Model.Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis.Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over timeKidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury.Wnt4 is a novel biomarker for the early detection of kidney tubular injury after ischemia/reperfusion injuryA rapid urine test for early detection of kidney injury.Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium.High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients.Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicityRenal dysfunction in acute heart failure: epidemiology, mechanisms and assessment.Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells?The effect of antiepileptic drugs on the kidney function and structure.Urinary biomarkers in the early detection and follow-up of tubular injury in childhood urolithiasis.Renal neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 expression in children with acute kidney injury and Henoch-Schönlein purpura nephritis.
P2860
Q26829452-A231CD1C-A1DD-46D4-AC3E-F05B73B6C1D0Q28570560-0C06D493-CA02-4936-A3B8-688BA5C80DD7Q28572929-179D1919-24B4-4C85-A531-B67456C5ED53Q28581371-CD306B50-925A-4DE6-860C-F7A268485F59Q33691277-01A55098-11A5-43A6-A98A-AD307DB95C24Q33727136-FCC0B2AD-4552-4DB1-ABC2-BD1BF891308DQ33764140-3FE60890-8F86-40DC-B212-F46BED990A34Q33913977-518418CA-7A7C-433F-924E-9E71457DA1ECQ34021381-4ECF28E5-E68F-4B38-B7F2-79F7CE5D8148Q34042098-C06EE203-D880-410F-B2D1-4869350BEAB6Q34260018-B3104DFE-6A87-484F-9384-4760881EA092Q34344501-68391612-E1EE-40D0-8351-3AE2E3FACB9AQ34670737-51E1A7EE-9B3B-40B4-A5A7-B2E9DC9A7D81Q34803229-B51B9BE1-8A00-4F5E-BDC6-532F4505E89BQ35203400-B3450DC7-C781-4308-AAA3-D5DC8C3C5E6DQ35819489-18C521D1-FE7A-4931-9E54-AF75DE2C12DFQ35867619-CD081D31-89A1-4712-88B5-9C009E4766EDQ35896606-BDDC9176-4A2E-424A-940D-05B2675C1285Q36207035-338EFE74-EDFF-4814-9DFD-2B7FD5229B19Q36290085-B02858CC-5B07-4EDD-97AC-F498A73A0457Q36609753-40E43FE3-79AF-436C-8841-5A25DD785367Q36677363-B7D693E5-836E-4DAA-8BAE-1B25233696AFQ36861560-4F358CAD-C280-42C0-8EFC-5DBF8E646445Q36877109-BECB0FA5-5DD3-48A9-9342-D10E9149F022Q37023637-594D2F92-A7BC-4FC2-BAFA-F879A4E65C38Q37052029-776F9017-8C98-42B0-8D84-F52FB4DF4FF6Q37128891-43C68207-1BCE-4CA1-B50C-C527773F333CQ37190253-89E7F6EE-AC95-445A-9F54-EC5380517EB6Q37196891-F60B8E60-9C60-40FA-AC3F-A3C64037FFDDQ37236924-BF326269-207F-43BD-A1B8-0562F8747A2EQ37331901-D5612CA7-8834-4CB1-AB97-C669F6899619Q37348057-FD7FB837-855A-4B50-BAA0-97D687EB24C0Q37349333-B8662ED9-291C-42F2-81AA-50F5464EB74DQ37355170-18C0A4AE-3B9A-4040-96EB-725EB51B124EQ37900203-FF9A47BE-FF53-481C-86A8-BE7D372220F6Q38053941-1C58CA89-3477-4936-8ECD-CF82345A9268Q38054004-7C4E9298-6740-4D9E-8707-28089B50C7C6Q38687924-F3A86D7A-524E-4A86-8CEE-1790D391E184Q38707750-9D39C9E0-B38C-417B-B336-1AD557DB3326Q38826221-8603C4F8-F69F-451B-A606-93402F77F155
P2860
Tubular kidney injury molecule-1 in protein-overload nephropathy
description
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im August 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/08/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/08/01)
@nl
наукова стаття, опублікована в серпні 2006
@uk
مقالة علمية (نشرت في أغسطس 2006)
@ar
name
Tubular kidney injury molecule-1 in protein-overload nephropathy
@ast
Tubular kidney injury molecule-1 in protein-overload nephropathy
@en
Tubular kidney injury molecule-1 in protein-overload nephropathy
@nl
type
label
Tubular kidney injury molecule-1 in protein-overload nephropathy
@ast
Tubular kidney injury molecule-1 in protein-overload nephropathy
@en
Tubular kidney injury molecule-1 in protein-overload nephropathy
@nl
prefLabel
Tubular kidney injury molecule-1 in protein-overload nephropathy
@ast
Tubular kidney injury molecule-1 in protein-overload nephropathy
@en
Tubular kidney injury molecule-1 in protein-overload nephropathy
@nl
P2093
P3181
P1476
Tubular kidney injury molecule-1 in protein-overload nephropathy
@en
P2093
Coen A. Stegeman
Jeffrey Damman
Joseph V. Bonventre
Mirjan M. van Timmeren
Stephan J. L. Bakker
Theo A. Schuurs
Veronique Bailly
Vishal S. Vaidya
P304
P3181
P356
10.1152/AJPRENAL.00403.2005
P577
2006-08-01T00:00:00Z